We modeled temporal trends in the 1- and 5-year survival of 32 499 patients with adenocarcinoma and squamous cell carcinoma of the lung in the Swedish Cancer Register between 1961 and 2000. The 1-year relative survival for adenocarcinoma improved from 37 % for patients diagnosed 1961–1965 to 45 % for those diagnosed 1996–2000 and from 39 to 45 % for squamous cell carcinoma. The adjusted excess mortality ratios for the period 1996–2000 compared with 1961–1965 were 0.80 for adenocarcinoma and 0.81 for squamous cell carcinoma. Thus, a previous report in a Dutch study of a relatively worsening prognosis for adenocarcinoma over time could not be confirmed
Introduction: Most patients diagnosed with non-small cell lung cancer (NSCLC) die within the first f...
Background Analysis of trends in cancer survival in defined well surveilled populations can provide ...
Background: As part of I-O Optimise, a multinational research platform providing real-world insights...
Objective: Lung cancer is often diagnosed at an advanced stage and survival has been poor, although ...
Introduction There have been significant changes in both diagnostic procedures and therapy for lung ...
textabstractIn this thesis trends in the incidence and survival of patients with lung cancer since 1...
Introduction: Lung cancer is the leading cause of cancer mortality worldwide. We analyzed changes in...
Abstract Aims: Global survival studies in cancer have generally shown favourable development, but st...
INTRODUCTION: Lung cancer is the leading cause of cancer mortality worldwide. We analyzed changes in...
Introduction:Lung cancer is the leading cause of cancer mortality worldwide. We analyzed changes in ...
Background: In comparison with other European and North American countries, England has poor surviva...
Lung cancer mortality patterns throughout Europe are very heterogeneous and largely reflect past smo...
IntroductionMost patients diagnosed with non-small cell lung cancer (NSCLC) die within the first few...
Global survival studies have shown favorable development in most cancers but few studies have consid...
ObjectiveFive-year survival after the diagnosis of non–small cell lung cancer is the most common ben...
Introduction: Most patients diagnosed with non-small cell lung cancer (NSCLC) die within the first f...
Background Analysis of trends in cancer survival in defined well surveilled populations can provide ...
Background: As part of I-O Optimise, a multinational research platform providing real-world insights...
Objective: Lung cancer is often diagnosed at an advanced stage and survival has been poor, although ...
Introduction There have been significant changes in both diagnostic procedures and therapy for lung ...
textabstractIn this thesis trends in the incidence and survival of patients with lung cancer since 1...
Introduction: Lung cancer is the leading cause of cancer mortality worldwide. We analyzed changes in...
Abstract Aims: Global survival studies in cancer have generally shown favourable development, but st...
INTRODUCTION: Lung cancer is the leading cause of cancer mortality worldwide. We analyzed changes in...
Introduction:Lung cancer is the leading cause of cancer mortality worldwide. We analyzed changes in ...
Background: In comparison with other European and North American countries, England has poor surviva...
Lung cancer mortality patterns throughout Europe are very heterogeneous and largely reflect past smo...
IntroductionMost patients diagnosed with non-small cell lung cancer (NSCLC) die within the first few...
Global survival studies have shown favorable development in most cancers but few studies have consid...
ObjectiveFive-year survival after the diagnosis of non–small cell lung cancer is the most common ben...
Introduction: Most patients diagnosed with non-small cell lung cancer (NSCLC) die within the first f...
Background Analysis of trends in cancer survival in defined well surveilled populations can provide ...
Background: As part of I-O Optimise, a multinational research platform providing real-world insights...